Bausch Health
BHC
#4785
Rank
โ‚น176.59 B
Marketcap
โ‚น475.68
Share price
-1.95%
Change (1 day)
-14.18%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น91.91. In 2024 the company made an earnings per share (EPS) of -โ‚น11.37 an increase over its 2023 EPS that were of -โ‚น153.51.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-844.9%
2024-โ‚น11.37-92.59%
2023-โ‚น153.51160.89%
2022-โ‚น58.84-76.64%
2021-โ‚น251.8668.45%
2020-โ‚น149.52-68.91%
2019-โ‚น480.89-57.11%
2018-โ‚น1,121-272.22%
2017โ‚น651.09-199.29%
2016-โ‚น655.72798.7%
2015-โ‚น72.96-128.31%
2014โ‚น257.74-204.62%
2013-โ‚น246.37602.7%
2012-โ‚น35.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.74-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น90.02-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA